This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Project:Interface/Substance/Documentation: Difference between revisions
>Rhz →Nomenclature: added InChI to nomenclature |
>Oskykins No edit summary |
||
| (14 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTITLE__ | |||
{| width="100%IT'LE' | |||
|- | |||
| colspan="2" style="width:100%; padding-bottom:10px; margin-bottom: 5px; border-bottom: 1px solid black; vertical-align:top; | | |||
=psilacetin.psychonautwiki.org= | |||
I have drafted a solution below which describes a suitable data model for storing substance article content as semantic sub-objects which would be rendered using a master template for the published article, allowing modification of variables via form interfaces by contributors. | I have drafted a solution below which describes a suitable data model for storing substance article content as semantic sub-objects which would be rendered using a master template for the published article, allowing modification of variables via form interfaces by contributors. | ||
Left column is for cultural information, speculation, and other basic material. Bottom Row is for semantic data collected from the trip reporter and presented as graphs, charts, and in tabular dorm. | |||
|- | |- | ||
| | | style="width:50%; padding-right:10px; margin-right:5px; border-right:1px solid black; vertical-align:top; | | ||
This shit right here, is the nuts. | |||
==Abstract== | ==Abstract== | ||
This is the introductory paragraph for the substance article, which should contain a summary of the information on this article for use in API calls and search results so that readers can quickly identify the substance. | This is the introductory paragraph for the substance article, which should contain a summary of the information on this article for use in API calls and search results so that readers can quickly identify the substance. | ||
== | ==Overview== | ||
This section contains information about the history, development, availability, and popularity of the substance: | This section contains information about the history, development, availability, and popularity of the substance: | ||
| Line 47: | Line 58: | ||
* ''Description of structure from IUPAC name'' | * ''Description of structure from IUPAC name'' | ||
* ''Structural comparison to similar compounds'' | * ''Structural comparison to similar compounds'' | ||
* '' | * ''Discussion of structure-activity relationship'' | ||
===Physical properties=== | ===Physical properties=== | ||
| Line 64: | Line 75: | ||
These sections will be used to discuss the physical and psychoactive consequences of administering the substance: | These sections will be used to discuss the physical and psychoactive consequences of administering the substance: | ||
==Pharmacodynamics== | |||
====Risk factors==== | ====Risk factors==== | ||
| Line 72: | Line 83: | ||
* ''Indications for the therapeutic use of the substance'' | * ''Indications for the therapeutic use of the substance'' | ||
= | ====Pharmacokinetics=== | ||
===Pharmacokinetics=== | |||
* ''Receptor selectivity and affinities'' | * ''Receptor selectivity and affinities'' | ||
* ''Metabolism for various routes of administration and forms of substance'' | * ''Metabolism for various routes of administration and forms of substance'' | ||
* ''Statistics and descriptions of possible side effects'' | * ''Statistics and descriptions of possible side effects'' | ||
==Toxicity and harm potential== | |||
* ''Toxicity of substance'' | * ''Toxicity of substance'' | ||
* ''Dangerous drug interactions by co-administration of substances'' | * ''Dangerous drug interactions by co-administration of substances'' | ||
* ''Addiction potential of substance'' | * ''Addiction potential of substance'' | ||
| style="vertical-align:top;" | | ==Subjective effects== | ||
The effects listed below are based upon the [[subjective effects index]] and personal experiences of [[PsychonautWiki]] [[Special:TopUsers|contributors]]. The listed effects will rarely (if ever) occur all at once, but heavier dosages will increase the chances and are more likely to induce a full range of effects. | |||
{| width="100%" | |||
|- | |||
| style="width:50%;vertical-align:top;" | | |||
<div class="panel radius"> | |||
<h3 class="panel-header">Physical effects [[File:User.svg|x20px|right|link=]]</h3> | |||
<p class="panel-abstract">The physical effects of codeine can be broken down into several components which progressively intensify proportional to dosage. The general head space of codeine is described by many as one of intense euphoria, relaxation, anxiety suppression and pain relief. The most prominent of these cognitive effects include</p> | |||
<ul class="featured-table"> | |||
<li class="featured list-item"> | |||
<div class="media-body"> | |||
<h4 class="media-heading">[[Effect::Pain relief]]</h4> | |||
<p></p> | |||
</div> | |||
</li> | |||
<li class="featured list-item"> | |||
<div class="media-body"> | |||
<h4 class="media-heading">[[Effect::Physical euphoria]]</h4> | |||
<p>This particular substance can be considered as less intense in its physical euphoria when compared with that of [[morphine]] or [[diacetylmorphine]] (heroin) due to the upper limit of how much can be converted into its active form through metabolism. The sensation itself can be described as extreme feelings of intense physical comfort, warmth and physical blissful euphoria which spreads throughout the body.</p> | |||
</div> | |||
</li> | |||
<li class="featured list-item"> | |||
<div class="media-body"> | |||
<h4 class="media-heading">[[Effect::Itchiness]]</h4> | |||
<p>This compound presents greater amounts of itchiness due to higher amounts of histamine release in comparison to other [[opioids]].</p> | |||
</div> | |||
</li> | |||
<li class="featured list-item"> | |||
<div class="media-body"> | |||
<h4 class="media-heading">[[Effect::Respiratory depression]]</h4> | |||
<p>At low to moderate doses, this effect results in the sensation that the breath is slowed down mildly to moderately, but does not cause noticeable impairment. At high doses and overdoses, opioid-induced respiratory depression can result in a shortness of breath, abnormal breathing patterns, semi-consciousness, or unconsciousness. Severe overdoses can result in a coma or death without immediate medical attention.</p> | |||
</div> | |||
</li> | |||
<li class="featured list-item"> | |||
<div class="media-body"> | |||
<h4 class="media-heading">[[Effect::Sedation]]</h4> | |||
<p>At higher dosages, this compound can result in feelings of sedation and is considerably more sedating than that of [[oxycodone]] and [[hydrocodone]].</p> | |||
</div> | |||
</li> | |||
</ul> | |||
<ul class="featured-table"> | |||
<li class="list-item"><h4 class="media-heading">[[Effect::Constipation]]</h4></li> | |||
<li class="list-item"><h4 class="media-heading">[[Effect::Cough suppression]]</h4></li> | |||
<li class="list-item"><h4 class="media-heading">[[Effect::Difficulty urinating]]</h4></li> | |||
<li class="list-item"><h4 class="media-heading">[[Effect::Pupil constriction]]</h4></li> | |||
</ul> | |||
</div> | |||
| style="width:50%;vertical-align:top;" | | |||
<div class="panel radius"> | |||
<h3 class="panel-header">Cognitive effects [[File:User.svg|x20px|right|link=]]</h3> | |||
<p class="panel-abstract">The physical effects of codeine can be broken down into several components which progressively intensify proportional to dosage, and generally include</p> | |||
<ul class="featured-table"> | |||
<li class="featured list-item"> | |||
<div class="media-body"> | |||
<h4 class="media-heading">[[Effect::Cognitive euphoria]]</h4> | |||
<p>This particular substance can be considered as less intense in its cognitive euphoria when compared with that of [[morphine]] or [[diacetylmorphine]] (heroin) due to the upper limit of how much can be converted into its active form through metabolism. It is still, however, capable of extreme intensity and overwhelming bliss at heavier dosages with a low tolerance. The sensation itself can be described as powerful and overwhelming feeling of emotional bliss, contentment, and happiness.</p> | |||
</div> | |||
</li> | |||
</ul> | |||
<ul class="featured-table"> | |||
<li class="list-item"><h4 class="media-heading">[[Anxiety suppression]]</h4></li> | |||
<li class="list-item"><h4 class="media-heading">[[Compulsive redosing]]</h4></li> | |||
</ul> | |||
</div> | |||
|} | |||
==Gallery== | |||
==Related articles== | |||
==References== | |||
</references> | |||
| style="width:50%; padding-left:10px; margin-left: 5px; border-left: 1px solid black; vertical-align:top; | | |||
The right column is for scientific data, molecular and physical information. | |||
==Substance info box== | ==Substance info box== | ||
===Image of molecular structure=== | ===Image of molecular structure=== | ||
| Line 97: | Line 181: | ||
** Brand names | ** Brand names | ||
===Dosage=== | |- | ||
=== | | colspan="2" style="width:100%; padding-top:10px; margin-top: 5px; border-top: 1px solid black; vertical-align:top; | | ||
Bottom row is for charts, graphs, and numerical data collected by the trip reporter. This area will be used as a space to provide very detailed findings of our crowd-sourced research, | |||
==Reports== | |||
===Premise=== | |||
===Dosage/Duration timeline=== | |||
====Concludiond snd anslyses==== | |||
==Article information== | |||
===Contributors, last edit=== | |||
===Citations=== | |||
|} | |} | ||